COVID-19: AIIMS director gives big update on start of vaccination in India
AIIMS director Dr Randeep Guleria on Thursday (December 3) stated that India we now have two-three coronavirus vaccines that are of their closing trial stage. Dr Guleria expressed hope that by the top of December or early January we should always get emergency use authorisation from Indian regulatory authorities to begin giving COVID-19 vaccine to public.
According to Dr Guleria, the method of vaccinating the individuals will start within the subsequent two-three months after getting the required approvals from regulatory authorities.
“There is good data available that the vaccines are very safe. Safety & efficacy of vaccine not compromised at all. 70,000-80,000 volunteers given vaccine, no significant serious adverse effects seen. Data shows that in the short term vaccine is safe,” stated Dr Guleria.
Referring to a volunteer exhibiting opposed response throughout trial stage of a vaccine, Dr Guleria stated, “Chennai trial case is an incidental finding rather than related to vaccine. When we vaccinate a large number of people, some of them may have some other disease, which may not be related to vaccine.”
“Now, we’ve seen a decline in current wave & I hope this will continue if we are able to have a good #COVID19 appropriate behaviour. We’re close to having a big change related to a pandemic if we manage this behaviour for next 3 months,” he added.
Dr Guleria made the assertion only a day after the United Kingdom turned the primary nation within the Western world to approve the usage of Pfizer-BioNTech COVID-19 vaccine. The British authorities stated that the vaccine might be rolled out to be used from early subsequent week.
Live TV
“The government has today accepted the recommendation from the Independent Medicines and Healthcare products Regulatory Agency (MHRA) to approve Pfizer-BioNTech’s COVID-19 vaccine for use,” the federal government stated, including, “The vaccine will be made available across the UK from next week,” reported Reuters.
$(function() { return $("[data-sticky_column]").stick_in_parent({ parent: "[data-sticky_parent]" }); });
reset_scroll = function() { var scroller; scroller = $("body,html"); scroller.stop(true); if ($(window).scrollTop() !== 0) { scroller.animate({ scrollTop: 0 }, "fast"); } return scroller; };
window.scroll_it = function() { var max; max = $(document).height() - $(window).height(); return reset_scroll().animate({ scrollTop: max }, max * 3).delay(100).animate({ scrollTop: 0 }, max * 3); };
window.scroll_it_wobble = function() { var max, third; max = $(document).height() - $(window).height(); third = Math.floor(max / 3); return reset_scroll().animate({ scrollTop: third * 2 }, max * 3).delay(100).animate({ scrollTop: third }, max * 3).delay(100).animate({ scrollTop: max }, max * 3).delay(100).animate({ scrollTop: 0 }, max * 3); };
$(window).on("resize", (function(_this) { return function(e) { return $(document.body).trigger("sticky_kit:recalc"); }; })(this));
}).call(this);
} on_load_google_ad(); function sendAdserverRequest() { try { if (pbjs && pbjs.adserverRequestSent) return; googletag.cmd.push(function() { googletag.pubads().refresh(); }); } catch (e) {
googletag.cmd.push(function() { googletag.pubads().refresh(); }); } } setTimeout(function() { sendAdserverRequest(); }, 5000);
function on_load_fb_twitter_widgets(){ (function(d, s, id) { var js, fjs = d.getElementsByTagName(s)[0]; if (d.getElementById(id)) return; js = d.createElement(s); js.id = id; js.src = "https://connect.facebook.net/en_US/sdk.js#xfbml=1&version=v2.9"; fjs.parentNode.insertBefore(js, fjs); }(document, 'script', 'facebook-jssdk'));
window.twttr = (function(d, s, id) { var js, fjs = d.getElementsByTagName(s)[0], t = window.twttr || {}; if (d.getElementById(id)) return t; js = d.createElement(s); js.id = id; js.src = "https://platform.twitter.com/widgets.js"; fjs.parentNode.insertBefore(js, fjs); t._e = []; t.ready = function(f) {
t._e.push(f); }; return t; }(document, "script", "twitter-wjs")); }
//setTimeout(function() { on_load_google_ad(); }, 5000); setTimeout(function() { on_load_fb_twitter_widgets(); }, 5000);
Source